Just my personal opinion, but if I was AMRN I would be intentionally slow walking the EMA process so I don't get formal approval before the appeal results are known - preserves maximum shareholder value. Whether it's immoral to delay people in the EU from getting V for a few extra months I sort of doubt it - we know the event rate curves didn't start to separate until somewhere between 1.5 and 2 yrs, so a few months may make no difference in outcomes. V isn't like an oncology drug where a delay of months could mean the diff between life and death.
News 
Market Data 
Discover 
AI
